| Tracy A Donahue, FNP | |
|
14540 Prairie Lakes Blvd N, Suite 207, Noblesville, IN 46060-4366 | |
| (317) 621-2455 | |
| (317) 355-6166 |
| Full Name | Tracy A Donahue |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 27 Years |
| Location | 14540 Prairie Lakes Blvd N, Noblesville, Indiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093718173 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 71000396A (Indiana) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Academy Allergy Asthma And Sinus, Pc | 4284614975 | 3 |
News Archive
Professor John Shine AO FAA, Executive Director of Sydney's Garvan Institute of Medical Research, received the 2010 Prime Minister's Prize for Science, the nation's most highly respected award for scientific achievement, in Parliament House tonight.
Regeneron Pharmaceuticals, Inc. and Sanofi today announced that the U.S. Food and Drug Administration approved Praluent (alirocumab) Injection, the first FDA-approved treatment in a new class of drugs known as PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitors.
With the 2010 Winter Olympic Games just days away, officials in the anti-doping community are urging researchers and those in the athletic community to re-double their efforts to fight illegal doping.
MDS Inc., a leading provider of products and services to the global life sciences markets, today announced that it has signed an agreement to sell its Central Labs operation, which conducts analysis of samples from late-stage clinical trials to Czura Thornton, a private investment group based in Jersey, Channel Islands.
› Verified 5 days ago
| Entity Name | Academy Allergy Asthma & Sinus, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780653535 PECOS PAC ID: 4284614975 Enrollment ID: O20040722001196 |
News Archive
Professor John Shine AO FAA, Executive Director of Sydney's Garvan Institute of Medical Research, received the 2010 Prime Minister's Prize for Science, the nation's most highly respected award for scientific achievement, in Parliament House tonight.
Regeneron Pharmaceuticals, Inc. and Sanofi today announced that the U.S. Food and Drug Administration approved Praluent (alirocumab) Injection, the first FDA-approved treatment in a new class of drugs known as PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitors.
With the 2010 Winter Olympic Games just days away, officials in the anti-doping community are urging researchers and those in the athletic community to re-double their efforts to fight illegal doping.
MDS Inc., a leading provider of products and services to the global life sciences markets, today announced that it has signed an agreement to sell its Central Labs operation, which conducts analysis of samples from late-stage clinical trials to Czura Thornton, a private investment group based in Jersey, Channel Islands.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tracy A Donahue, FNP 14540 Prairie Lakes Blvd N, Suite 207, Noblesville, IN 46060-4366 Ph: (317) 621-2455 | Tracy A Donahue, FNP 14540 Prairie Lakes Blvd N, Suite 207, Noblesville, IN 46060-4366 Ph: (317) 621-2455 |
News Archive
Professor John Shine AO FAA, Executive Director of Sydney's Garvan Institute of Medical Research, received the 2010 Prime Minister's Prize for Science, the nation's most highly respected award for scientific achievement, in Parliament House tonight.
Regeneron Pharmaceuticals, Inc. and Sanofi today announced that the U.S. Food and Drug Administration approved Praluent (alirocumab) Injection, the first FDA-approved treatment in a new class of drugs known as PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitors.
With the 2010 Winter Olympic Games just days away, officials in the anti-doping community are urging researchers and those in the athletic community to re-double their efforts to fight illegal doping.
MDS Inc., a leading provider of products and services to the global life sciences markets, today announced that it has signed an agreement to sell its Central Labs operation, which conducts analysis of samples from late-stage clinical trials to Czura Thornton, a private investment group based in Jersey, Channel Islands.
› Verified 5 days ago
Heather Lynn Lutz, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 18051 River Rd Ste 105, Noblesville, IN 46062 Phone: 317-570-7900 Fax: 317-570-2286 | |
Kaitlyn Nicole Dervenis, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 493 Westfield Rd, Noblesville, IN 46060 Phone: 317-363-9788 | |
Krista M Spalding, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 355 Westfield Rd Ste 114, Noblesville, IN 46060 Phone: 317-770-2937 Fax: 317-770-2938 | |
Jacqueline L Seacat, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 865 Westfield Rd, Noblesville, IN 46062 Phone: 317-776-3854 Fax: 317-776-3854 | |
Ashley Renee Miller, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 865 Westfield Rd Ste D, Noblesville, IN 46062 Phone: 317-776-3851 Fax: 317-776-3854 | |
Ms. Mary Ann Ruff-troup, FNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 5695 Pebble Village Ln, Noblesville, IN 46062 Phone: 317-450-7722 |